The tumour marker that shows which brain cancer patients in Singapore has a better chance of living longer
The result of the newly published research study, in the scientific journal BMC Cancer, showed that patients diagnosed with high grade glioma who have the tumour marker (MGMT promoter methylation) lived longer than those who did not.